Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azorin

Showing results (21-30 of 581) with videos related to

Pageof 59
Sort By:
L'Encephale|September 1, 1988
[Tardive dyskinesia and affective disorders]J M Azorin, P Thermoz
L'Encephale|November 24, 2018
[Aripiprazole as dopamine partial agonist model: Basic concepts and clinical impact]N Simon, J-M Azorin
Expert Opinion on Pharmacotherapy|July 19, 2012
Clozapine for the treatment of schizophreniaEric Fakra, Jean-Michel Azorin
Pharmacopsychiatry|September 1, 1987
Kindling models and antikindling effects of mood normalizersJ M Azorin, V Tramoni
American Journal of Medical Genetics|November 29, 2002
Schizophrenia: two-faced meaning of vulnerabilityJean-Michel Azorin, Jean Naudin
Drugs|August 31, 2019
Dopamine Receptor Partial Agonists for the Treatment of Bipolar DisorderJean-Michel Azorin, Nicolas Simon
Expert Opinion on Pharmacotherapy|February 25, 2009
An update on the treatment of bipolar depressionJean-Michel Azorin, Arthur Kaladjian
L'Encephale|March 14, 2015
[Rational estimation of drug dosage through pharmacometric modeling: The case of a long-acting depot antipsychotic]N Simon, J-M Azorin
Revue Du Rhumatisme (Ed. Francaise : 1993)|November 30, 1993
[Post-traumatic coxarthrosis. Medicolegal conditions of the likelihood of fractures, luxations or contusions]M Lequesne, M Azorin, J Lamotte
Nucleic Acids Research|August 1, 1996
TBP binds the transcriptionally inactive TA5 sequence but the resulting complex is not efficiently recognised by TFIIB and TFIIAJ Bernués, P Carrera, F Azorin
Pageof 59

Showing results (21-30 of 581) with videos related to

Sort By:
Pageof 59
L'Encephale|September 1, 1988
[Tardive dyskinesia and affective disorders]J M Azorin, P Thermoz
L'Encephale|November 24, 2018
[Aripiprazole as dopamine partial agonist model: Basic concepts and clinical impact]N Simon, J-M Azorin
Expert Opinion on Pharmacotherapy|July 19, 2012
Clozapine for the treatment of schizophreniaEric Fakra, Jean-Michel Azorin
Pharmacopsychiatry|September 1, 1987
Kindling models and antikindling effects of mood normalizersJ M Azorin, V Tramoni
American Journal of Medical Genetics|November 29, 2002
Schizophrenia: two-faced meaning of vulnerabilityJean-Michel Azorin, Jean Naudin
Drugs|August 31, 2019
Dopamine Receptor Partial Agonists for the Treatment of Bipolar DisorderJean-Michel Azorin, Nicolas Simon
Expert Opinion on Pharmacotherapy|February 25, 2009
An update on the treatment of bipolar depressionJean-Michel Azorin, Arthur Kaladjian
L'Encephale|March 14, 2015
[Rational estimation of drug dosage through pharmacometric modeling: The case of a long-acting depot antipsychotic]N Simon, J-M Azorin
Revue Du Rhumatisme (Ed. Francaise : 1993)|November 30, 1993
[Post-traumatic coxarthrosis. Medicolegal conditions of the likelihood of fractures, luxations or contusions]M Lequesne, M Azorin, J Lamotte
Nucleic Acids Research|August 1, 1996
TBP binds the transcriptionally inactive TA5 sequence but the resulting complex is not efficiently recognised by TFIIB and TFIIAJ Bernués, P Carrera, F Azorin
Pageof 59